Company Description
At hear.com, we are on a mission to bring high quality hearing care to anyone, anywhere.
Since our founding in 2012, we have grown rapidly to become the largest online provider of expert, medical-grade hearing care globally.
We reimagined the hearing care delivery model and pioneered a digital platform that enables us to deliver a highly engaging, end-to-end customer experience, which we call our Hearing Success Program.
We first meet our consumers online before engaging with them telephonically to provide individualized advice on hearing care, dispel any misconceptions and generate excitement.
Once the consumer decides to continue with hearing tests and fittings, we meet them locally through our global network of over 5,000 handpicked clinic locations, which we refer to as our partner providers, or remotely through our proprietary Clinic-in-a-Box, which is our teleaudiology solution.
Our data-driven approach to hearing care enables us to deliver a personalized experience and respond to customer needs in real time.
Our continued investment in technology and data analytics is geared towards maximizing customer satisfaction, allowing us to connect with a broad unpenetrated base of consumers and redefine what it means to experience and treat hearing loss today.
Country | The Netherlands |
Founded | 2015 |
Industry | Health Services |
Sector | Healthcare |
Employees | 1,388 |
CEO | Paul Crusius and Marco Vietor, PhD |
Contact Details
Address: Amsterdamsestraatweg 421 Utrecht, 3551 CL The Netherlands | |
Phone | +31 55 80 80 140 |
Website | hear.com |
Stock Details
Ticker Symbol | HCG |
Exchange | NASDAQ |
Reporting Currency | EUR |
CIK Code | 0001837978 |
SIC Code | 8090 |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Mar 16, 2022 | RW | Filing |
May 7, 2021 | FWP | Free Writing Prospectus |
May 7, 2021 | F-1/A | [Amend] Registration statement for certain foreign private issuers |
May 5, 2021 | F-1/A | [Amend] Registration statement for certain foreign private issuers |
May 3, 2021 | F-1/A | [Amend] Registration statement for certain foreign private issuers |
Apr 19, 2021 | F-1 | Registration statement for certain foreign private issuers |
Apr 1, 2021 | DRS/A | [Amend] [Cover] Draft Registration Statement |
Mar 15, 2021 | DRS/A | [Amend] [Cover] Draft Registration Statement |
Feb 8, 2021 | DRS | [Cover] Draft Registration Statement |